PRISM, RDoC, and neuropsychiatric diseases – Interview with Dr Bruce Cuthbert

Dr Cuthbert recently spoke to ECNP press officer Tom Parkhill about RDoC, PRISM, and the future of research into the causes and treatment of mental health issues.

Click here to read the full interview.

The PRISM 2 project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101034377. The JU receives support from the European Union’s Horizon 2020 research and innovation programme, EFPIA, and Cohen Veterans Bioscience (CVB). The website reflects only the authors' views and IMI JU, EFPIA, CVB, and the European Commission are not responsible for any use that may be made of the information it contains.